301 Binney Street
available to Lease
in Cambridge, MA
posted on May 30, 2012
Director of Economic Development
BioMed Realty Trust and Richards Barry Joyce & Partners are pleased to present an exciting leasing opportunity at 301 Binney Street in Cambridge, Massachusetts.
301 Binney Street features 410,151 RSF of First Class Office/R&D space in the heart of the Kendall Square/East Cambridge Biotechnology Market. The building sits over a subgrade garage and features a superior laboratory base building shell.
Tenants will enjoy excellent access via I-93, close proximity to the Red Line (Kendall) and the Green Line (Lechmere) MBTA Stations and the EZ Ride Shuttle Bus. Tenants participate in a thriving neighborhood community with shops, restaurants and cinemas at Kendall Square. Neighboring institutions and corporations include MIT, Genzyme, Amgen, Biogen, Broad Institute, Whitehead Institute, Millennium Pharmaceuticals and Vertex Pharmaceuticals.
Biotech Infrastructure Amenities
410,151 rentable square feet
Floor to Floor Height:
•14 ft. on Floors 1 thru 5
•18 ft. for the mechanical Penthouse
•33' x 33'
•100 lbs. per RSF on Floors 1 thru 5
•100 lbs. per RSF on Roof
•250 lbs. per RSF on enclosed
•Common Area: automatic wet-pipe sprinkler and manual wet standpipes HVAC
•Four 1500 ton chillers
•Four 600 bhp boiler units
•Eight cooling towers on rooftop
•AHU designed to deliver 2 cfm/sf
•8 AHUs per floor
•300 KVA Life safety generator
•Four traction passenger elevators with 3,500 lbs. capacity
•Two traction freight elevators with 10,000 lbs. capacity
•1 per 1,000 USF (less mechanical)
•One shared central dock equipped with three vehicle access spaces
|Property Use||Lab, Office|
|Parking||This property has parking available|
|Building Size (in Square Feet)||410,151|
|Square feet available||90,000|
|Date of Construction||2008|
|Property Owner||BioMed Realty Trust|
Images (Click on images to view larger size)
MassBio is a not-for-profit organization committed to advancing the development of critical new science, technology and medicines that benefit people worldwide.
Founded in 1985, MassBio represents over 600 biotechnology companies, academic institutions, research hospitals, and service organizations involved in life sciences and health care, and works to advance policy and promote education, while providing member programs and events, industry information, and services.
- January 26, 2015 MassBio Office Closed 1/27
- January 23, 2015 Supporting Increased NIH Funding
- January 7, 2015 Bio-Pact Establishes Corporate HQ in Massachusetts
- December 30, 2014 FREE DOT Hazmat Training for MassBio Members (Webex)
- December 9, 2014 Q & A with Dr. David Meeker, President and Chief Executive Officer of Genzyme